Skip to main content

Alx Oncology Holdings Inc

ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810182

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Alx Oncology Holdings Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
2 insiders, $8.27K in total
Insiders trading
2
Net value
−$8.27K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Alx Oncology Holdings Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Alx Oncology Holdings Inc
NameTitleLast reported holdingLast filingFilings, past year
Lettmann JasonCHIEF EXECUTIVE OFFICER294,379Aug 18, 20265
Pinto ShellySVP, FINANCE AND CAO87,828Aug 18, 20267
Klencke BarbaraChief Medical Officer–Apr 17, 20262
Knight Jeff E.Chief Dev & Operating Officer–Apr 17, 20261
Goodman Corey SDirector, 10% Owner8,453,038IndirectFeb 4, 20262
Shantharam HarishChief Financial Officer75,000Jan 28, 20262
Garland J. ScottDirector–Jan 21, 20261
Takimoto Chris HDirector–Jan 21, 20261
Hemrajani RekhaDirector33,000Jan 21, 20261
Sandler Alan B.Director–Jan 21, 20261
Curran Daniel J.Director–Jan 21, 20261
Pons JaumePRESIDENT & CSO579,388Feb 21, 20250
Garcia Peter SCHIEF FINANCIAL OFFICER121,516Aug 16, 20240
Randolph SophiaCHIEF MEDICAL OFFICER325,711Aug 16, 20240
Nielsen JackDirector, 10% Owner–Jun 22, 20230
Canamasas ItziarDirector–Jun 22, 20230
George Jean10% Owner285,956IndirectDec 15, 20210
Carusi Michael A10% Owner285,956IndirectDec 15, 20210
Plain Henry A JR10% Owner285,956IndirectDec 15, 20210
Lightstone Ventures, L.P.10% Owner285,956IndirectDec 15, 20210
Lightstone Ventures (A), L.P.10% Owner285,956IndirectDec 15, 20210
LSV Associates, LLC10% Owner285,956IndirectDec 15, 20210
Lightstone Ventures II, L.P.10% Owner285,956IndirectDec 15, 20210
Lightstone Ventures II (A), L.P.10% Owner285,956IndirectDec 15, 20210
LSV Associates II, LLC10% Owner285,956IndirectDec 15, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 14, 2021 (view filing)Jul 122 daysRandolph SophiaChief Medical OfficerSSale−7.39K$54.90−$405.6K−4.1%171.6K after2 lots
Jul 20, 2021 (view filing)Jul 191 dayPons JaumePresident & CEOSSale−16.7K$54.56−$911.2K−3.3%494.5K after3 lots
Aug 11, 2021 (view filing)Aug 101 dayRandolph SophiaChief Medical OfficerSSale−7.39K$64.64−$477.5K−4.3%164.2K after3 lots
Aug 18, 2021 (view filing)Aug 171 dayGarcia Peter SChief Financial OfficerSSale−10.0K$66.23−$662.3K−51.7%9.33K after5 lots
Aug 20, 2021 (view filing)Aug 191 dayPons JaumePresident & CEOSSale−16.7K$61.28−$1.02M−3.4%478.0K after7 lots
Aug 24, 2021 (view filing)Aug 231 dayGarcia Peter SChief Financial OfficerSSale−60.0K$74.15−$4.45M−86.5%9.33K after8 lots
Sep 13, 2021 (view filing)Sep 103 daysRandolph SophiaChief Medical OfficerSSale−7.39K$77.66−$573.7K−4.5%156.8K after3 lots
Sep 17, 2021 (view filing)Sep 16-171 dayGarcia Peter SChief Financial OfficerSSale−12.8K$79.12−$1.01M−57.8%9.33K after6 lots
Sep 21, 2021 (view filing)Sep 201 dayPons JaumePresident & CEOSSale−16.7K$74.39−$1.24M−3.5%461.3K after4 lots
Oct 12, 2021 (view filing)Oct 111 dayRandolph SophiaChief Medical OfficerSSale−7.39K$60.98−$450.4K−4.7%149.4K after2 lots
Oct 19, 2021 (view filing)Oct 181 dayGarcia Peter SChief Financial OfficerSSale−7.23K$55.44−$400.8K−43.7%9.33K after6 lots
Oct 20, 2021 (view filing)Oct 191 dayPons JaumePresident & CEOSSale−16.7K$54.30−$906.8K−3.6%444.6K after2 lots
Oct 20, 2021 (view filing)Oct 191 dayPons JaumePresident & CEOSSale−16.7K$54.30−$906.8K−3.6%444.6K after2 lotsDuplicate filing
Nov 23, 2021 (view filing)Nov 221 dayRandolph SophiaChief Medical OfficerSSale−14.9K$36.77−$547.3K−8.3%164.5K after
Dec 10, 2021 (view filing)Dec 8-102 daysLettmann JasonDirector, 10% OwnerSSale−145.6K$32.26−$4.70M−33.3%291.8K after16 lots
Dec 10, 2021 (view filing)7:51 PM ETDec 8-102 daysGeorge Jean and 8 others10% OwnerSSale−145.6K$32.26−$4.70M−33.3%291.8K after16 lotsDuplicate filing
Dec 15, 2021 (view filing)9:03 PM ETDec 132 daysGeorge Jean and 8 others10% OwnerSSale−48.4K$26.61−$1.29M−14.5%286.0K after12 lots
Dec 15, 2021 (view filing)9:48 PM ETDec 132 daysLettmann JasonDirector, 10% OwnerSSale−325.4K$27.36−$8.90M−53.2%286.0K after12 lots
Jan 3, 2023 (view filing)Dec 29, 20225 daysPons JaumePresident & CEOSSale−3.23K$11.07−$35.8K−0.6%539.7K after
Jan 3, 2023 (view filing)Dec 29, 20225 daysGarcia Peter SChief Financial OfficerSSale−893$11.07−$9.89K−1.6%53.7K after
Jan 3, 2023 (view filing)Dec 29, 20225 daysRandolph SophiaChief Medical OfficerSSale−1.62K$11.07−$17.9K−0.6%270.3K after
Jan 3, 2023 (view filing)Dec 29, 20225 daysPinto ShellyVP, Finance and CAOSSale−482$11.07−$5.34K−0.8%62.1K after
Jul 5, 2023 (view filing)Jun 305 daysGarcia Peter SChief Financial OfficerSSale−887$7.34−$6.51K−1.6%54.7K after
Jul 5, 2023 (view filing)Jun 305 daysPinto ShellyVP, Finance and CAOSSale−466$7.34−$3.42K−0.7%63.1K after
Jul 5, 2023 (view filing)Jun 305 daysPons JaumePresident & CEOSSale−3.21K$7.34−$23.5K−0.6%536.5K after
Jul 5, 2023 (view filing)Jun 305 daysRandolph SophiaChief Medical OfficerSSale−1.60K$7.34−$11.8K−0.6%281.5K after
Jul 7, 2023 (view filing)Jul 61 dayPinto ShellyVP, Finance and CAOSSale−7.34K$6.52−$47.9K−11.6%55.7K after
Jan 3, 2024 (view filing)Dec 29, 20235 daysPons JaumePresident & CSOSSale−7.18K$15.04−$108.0K−1.1%618.4K after
Jan 3, 2024 (view filing)Dec 29, 20235 daysGarcia Peter SChief Financial OfficerSSale−1.89K$15.04−$28.5K−2.2%85.3K after
Jan 3, 2024 (view filing)Dec 29, 20235 daysRandolph SophiaChief Medical OfficerSSale−3.13K$15.04−$47.0K−1.0%312.3K after
Jan 3, 2024 (view filing)Dec 29, 20235 daysPinto ShellySVP, Finance and CAOSSale−1.63K$15.04−$24.5K−2.0%81.3K after
Jan 5, 2024 (view filing)Jan 41 dayPinto ShellySVP, Finance and CAOSSale−2.72K$13.60−$37.0K−3.3%78.6K after
Mar 18, 2024 (view filing)Mar 144 daysLettmann JasonCHIEF EXECUTIVE OFFICERPPurchase+4.40K$11.31+$49.8K+2.6%171.6K after
Apr 5, 2024 (view filing)Apr 41 dayPons JaumePRESIDENT & CSOSSale−20.0K$11.15−$223.0K−3.1%628.4K after10b5-1
Apr 18, 2024 (view filing)Apr 162 daysPons JaumePRESIDENT & CSOSSale−50.0K$14.20−$710.0K−7.6%604.2K after10b5-1
May 8, 2024 (view filing)May 62 daysPons JaumePRESIDENT & CSOSSale−20.0K$15.92−$318.4K−3.2%604.2K after10b5-1
May 15, 2024 (view filing)May 132 daysRandolph SophiaCHIEF MEDICAL OFFICERSSale−12.0K$15.95−$191.4K−3.5%330.3K after2 lots10b5-1
Jun 6, 2024 (view filing)Jun 42 daysPons JaumePRESIDENT & CSOSSale−20.0K$8.43−$168.6K−3.2%604.2K after10b5-1
Jun 24, 2024 (view filing)Jun 1311 daysGarcia Peter SCHIEF FINANCIAL OFFICERPPurchase+12.0K$8.53+$102.4K+10.9%122.3K afterAmended
Jul 3, 2024 (view filing)Jul 12 daysPons JaumePRESIDENT & CSOSSale−10.8K$5.82−$62.6K−1.8%593.4K after
Jul 3, 2024 (view filing)Jul 12 daysRandolph SophiaCHIEF MEDICAL OFFICERSSale−3.27K$5.82−$19.0K−1.0%327.1K after
Jul 3, 2024 (view filing)Jul 12 daysPinto ShellySVP, FINANCE AND CAOSSale−1.37K$5.82−$7.99K−1.4%93.9K after
Jul 9, 2024 (view filing)Jul 54 daysPinto ShellySVP, FINANCE AND CAOSSale−1.82K$5.50−$10.0K−1.9%92.1K after
Jul 15, 2024 (view filing)Jul 114 daysPons JaumePRESIDENT & CSOSSale−20.0K$7.90−$158.0K−3.3%593.4K after10b5-1
Aug 16, 2024 (view filing)Aug 142 daysPons JaumePRESIDENT & CSOSSale−1.94K$2.58−$5.00K−0.3%591.5K after
Aug 16, 2024 (view filing)Aug 142 daysRandolph SophiaCHIEF MEDICAL OFFICERSSale−1.36K$2.58−$3.52K−0.4%325.7K after
Aug 16, 2024 (view filing)Aug 142 daysPinto ShellySVP, FINANCE AND CAOSSale−564$2.58−$1.46K−0.6%91.5K after
Dec 4, 2024 (view filing)Dec 22 daysHemrajani RekhaDirectorPPurchase+30.0K$1.55+$46.5K+1,000.0%33.0K after
Jan 2, 2025 (view filing)Dec 30, 20243 daysPons JaumePRESIDENT & CSOSSale−10.8K$1.58−$17.1K−1.8%580.7K after
Jan 2, 2025 (view filing)Dec 30, 20243 daysPinto ShellyInterim CFOSSale−1.43K$1.58−$2.25K−1.6%90.1K after